Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

Spanish scientists have identified groups of genes associated with a predisposition to the development of ductal ...

Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced ...

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms ...

Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance innovative therapies from target identification ...

European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN: Stockholm Monday, January 19, 2026, 10:00 Hrs [IST] Sobi, a global biopharma company u ...

To complement recovery after an injury, a health reporter went the herbal route with a clinical expert's guidance. One bonus ...

For more than a century, maps of the brain have been based on how brain tissue looks under the microscope. These anatomical maps divide the brain into regions according to structural variations in the ...

The Health Information Law will start requiring providers to share information, such as vaccinations, medications, and ...

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Careboo, an innovator in therapeutic technology and ...

Platforms like Reddit, TikTok and YouTube host millions of posts, videos and comments, many filled with slang, sarcasm, ...

Sobi® (STO: SOBI), today announced that the European Commission (EC) has approved Aspaveli® (pegcetacoplan) for the treatment of adult ...